Latest Advances

  • Condition: Primary Sclerosing Cholangitis with Ulcerative Colitis
  • Journal: The Tohoku journal of experimental medicine
  • Treatment Used: Ursodeoxycholic Acid
  • Number of Patients: 1
  • Published —
This case report describes an 11-year-old girl diagnosed with ulcerative colitis who developed primary sclerosing cholangitis (bile duct inflammation) treated with ursodeoxycholic acid.
  • Condition: Cholangiocarcinoma
  • Journal: The Journal of international medical research
  • Treatment Used: Prednisolone, Teprenone, Potassium Chloride, and Calcium Carbonate
  • Number of Patients: 1
  • Published —
The study researched a case of cholangiocarcinoma.
  • Condition: Children and Adults with Primary Sclerosing Cholangitis (PSC)
  • Journal: Scandinavian journal of gastroenterology
  • Treatment Used: Oral Vancomycin (OV)
  • Number of Patients: 0
  • Published —
This study reported the long-term biochemical course and outcomes of patients with primary sclerosing cholangitis (inflamed bile duct; PSC) treated with oral vancomycin (OV).
  • Condition: Primary Sclerosing Cholangitis (PSC) and Primary Biliary Cholangitis (PBC)
  • Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
  • Treatment Used: Ursodeoxycholic acid or Obeticholic Acid
  • Number of Patients: 0
  • Published —
This article discusses the diagnosis and treatment of primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) immune-mediated chronic liver diseases.
  • Condition: IgG4-related Sclerosing Cholangitis
  • Journal: PloS one
  • Treatment Used: Endoscopic Biliary Drainage (EBD) and Corticosteroid (CS)
  • Number of Patients: 69
  • Published —
This study aimed to determine the best treatment approach, effectiveness, and safety for patients with IgG4-related sclerosing cholangitis (ISC) using endoscopic biliary drainage (EBD) and corticosteroid (CS).
  • Condition: Pouchitis in Inflammatory Bowel Disease
  • Journal: Arquivos de gastroenterologia
  • Treatment Used: Antibiotics, Probiotics, Thiopurine, and Biological Therapy
  • Number of Patients: 0
  • Published —
This article discusses the treatment of pouchitis in patients with inflammatory bowel disease.
  • Condition: Primary Sclerosing Cholangitis (PSC)
  • Journal: Journal of gastroenterology
  • Treatment Used: Ursodeoxycholic Acid (UDCA)
  • Number of Patients: 0
  • Published —
This article evaluates emerging treatment strategies for primary sclerosing cholangitis (PSC), a primary progressive liver disease.
  • Condition: Primary Sclerosing Cholangitis
  • Journal: United European gastroenterology journal
  • Treatment Used: Diclofenac
  • Number of Patients: 931
  • Published —
The study researched the use of Diclofenac in preventing primary sclerosing cholangitis.
  • Condition: Sclerosing Cholangitis
  • Journal: Scandinavian journal of gastroenterology
  • Treatment Used: Liver Transplantation
  • Number of Patients: 48
  • Published —
In this study, researchers evaluated the outcomes of undergoing liver transplantation for the treatment of sclerosing cholangitis.
  • Condition: Primary Sclerosing Cholangitis (PSC)
  • Journal: Journal of hepatology
  • Treatment Used: Obeticholic Acid (OCA)
  • Number of Patients: 76
  • Published —
This study investigated the safety and effectiveness of obeticholic acid (OCA) in the treatment of primary sclerosing cholangitis (liver disease; PSC).
  • Condition: Autoimmune Hepatitis (AIH)
  • Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • Treatment Used: Liver Transplantation (LT)
  • Number of Patients: 30970
  • Published —
This study analyzed long-term patient and graft survival after liver transplantation for autoimmune hepatitis (AIH-LT).
  • Condition: Primary Sclerosing Cholangitis (PSC)
  • Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Treatment Used: Tumor Necrosis Factor (TNF) Antagonists
  • Number of Patients: 141
  • Published —
This study evaluated the effects of tumor necrosis factor (TNF) antagonists (medicines that suppress the body's natural response to tumor necrosis factor, a protein produced by white blood cells that is involved in early inflammatory events) in patients with primary sclerosing cholangitis (chronic disease in which the bile ducts inside and outside the liver become inflamed and scarred, and eventually narrowed or blocked; PSC).
Showing 1-12 of 34